1. Ayoola EA, Odelola HA, Johnson AOK (1982) Primary liver cancer (PLC) after non-A, non-B hepatitis (NANBH) Hepatology 2: 154
2. Bosch FX, Munoz N (1991) Hepatocellular carcinoma in the world: epidemiologic questions. In: Tabor E, Di Bisceglie AM, Purcell RH (eds) Etiology, pathology and treatment of hepatocellular carcinoma in North America. Gulf, Houston, pp 35–54
3. Bottelli R, Mondazzi L, Asti L, Rezakovic I, Bellati G, Marotta F, Ideo G (1991) Confronting different methods in determination of anti-HCV antibodies in chronic liver disease. 3rd International Symposium on HCV, Strasbourg, Sept 16–17
4. Bruix J, Barrera JM, Calvet X, Costa J, Ventura M, Bruguera M, Castillo R, Ercilla G, Sanchez-Tapias JM, Vall M, Bru C, Rodes J (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2: 1004–1006
5. Bruno S, Sîlini E, Crosignani A, Bonino F, Leandro G, Bono F, Asti M, Rossi S, Larghi A, Cerino A, Podda M, Mondelli MU (1997) Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 25: 754–758